U.S. Markets closed

Avid Bioservices, Inc. (CDMO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
20.98+0.84 (+4.17%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close20.14
Open20.25
Bid19.60 x 800
Ask21.02 x 900
Day's Range19.98 - 21.15
52 Week Range6.89 - 28.36
Volume1,171,419
Avg. Volume581,076
Market Cap1.276B
Beta (5Y Monthly)2.22
PE Ratio (TTM)N/A
EPS (TTM)-0.00
Earnings DateJun 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.25
  • Zacks

    Down 20.1% in 4 Weeks, Here's Why Avid Bioservices (CDMO) Looks Ripe for a Turnaround

    Avid Bioservices (CDMO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

  • Motley Fool

    Avid Bioservices, inc (CDMO) Q1 2021 Earnings Call Transcript

    On today's call, we have Nick Green, President and CEO; and Dan Hart, Chief Financial Officer. Today, we'll be providing an overview of Avid Bioservices' contract development and manufacturing business, including updates on corporate activities and financial results for the quarter ended July 31, 2021.

  • GlobeNewswire

    Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2021 and Recent Developments

    -- Recorded First Quarter Revenue of $30.8 Million -- -- Achieved Fifth Consecutive Quarter of Operational Profitability -- -- Signed $23 Million in New Business Orders and Ended the Quarter with a Backlog of $110 Million -- -- Phase 1 and Phase 2 Expansion Efforts Advancing as Planned -- TUSTIN, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by prov